Novel Insight into the Agonistic Mechanism of Alefacept In Vivo: Differentially Expressed Genes May Serve as Biomarkers of Response in Psoriasis Patients
J Immunol Haider et al.
178: 7442
Data Supplement
Files in this Data Supplement:
Supplemental Table (XLS, 630 Kb)
-
Table 1a: Gene Products and systemic ID of genes listed in Figure 2A.
Table 1b: In-vitro gene regulation by alefacept.
Table 1c: Comparison of anti CD3/CD8 and alefacept activation.
Table 1d: Genes regulated in responders and non-responders at 6h posttreatment.
Table 1e: Genes uniquely regulated in responders or non-responders at 6h
posttreatment.
Table 1f: Genes up regulated in responders as compared to non-responders in pre-treatment blood.
Table 1g: Genes up regulated in non-responders as compared to responders in
pre-treatment blood.